One-Year Outcomes of Standalone XEN Gel Stent Versus Nonpenetrating Deep Sclerectomy. Touboul A, Fels A, Morin A, Bensmail D, et al. J Glaucoma 2022;31:955-965.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Touboul A, Fels A, Morin A, Bensmail D, et al. One-Year Outcomes of Standalone XEN Gel Stent Versus Nonpenetrating Deep Sclerectomy. J Glaucoma 2022;31:955-965.
PMID: 36001498